glp 1 ban Should GLP-1 agonists like Ozempic and Wegovy be banned for professional athletes? FDA Proposes Ban on Bulk
Description
More than one in ten people in Saudi Arabia is living with diabetes, and the prevalence of the disease will almost double by 2045, according to a report by the International Diabetes Federation
Therefore, when prescribing liraglutide, a balanced discussion is required between patients and medical staff about the expected therapeutic and side effects of the drug
doi: 10.1111/dom.13129
Semaglutide resulted in 7.9 to 16 percent greater reduction in body weight compared to the other drugs, for which the range was 5.0 to 9.9 percent
Metabolic labs: Fasting glucose, HbA1c, lipid panel, liver enzymes (ALT, AST)
